Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Date
2020-03
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2020, 'Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006', EFSA Journal, vol. 18, no. 3, e06004, pp. e06004. https://doi.org/10.2903/j.efsa.2020.6004